Govt Job: For M.Pharm or MSc to work with Govt of India | Salary upto Rs 90,000/- pm
Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India. The institute is an integral part…
WHO recommends Merck’s COVID pill for high-risk patients
A World Health Organization (WHO) panel on Wednesday backed the use of Merck & Co Inc’s COVID-19 antiviral pill for high-risk patients. The expert panel conditionally recommended the pill, molnupiravir,…
Govt Job: For M.Pharm, MSc in Ministry of Science and Technology, Govt of India
Translational Health Science and Technology Institute is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt, of India. The institute is an integral part of…
U.S. FDA declines to approve Gilead’s HIV drug on glass vial concerns
The U.S health regulator has declined to approve Gilead Sciences’ injectable drug for the treatment of HIV-1 infection over concerns related to the vials meant for the drug, the company said on…
Govt Job : For Pharmacist at SCTIMST – Govt of India | Pay upto Rs 1,12,400 pm
Originally established by the Government of Kerala as an advanced centre for medical specialties, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) metamorphosed into an Institution of National…
India And Japan To Strengthen Ties In Pharma And Healthcare
Bengaluru : India and Japan will strengthen ties in pharma and healthcare and will chip in expertise and experience. Seven Japanese companies with deep-tech solutions in the fields of medicine,…
Commerce Ministry Relaxes Most Of Restrictions On Exports
New Delhi : The ministry of commerce and industry has stated that it has relaxed most of the restrictions or prohibitions imposed by the Ministry on the products including drug…
Govt Job: For M.Pharm and M.Sc in research at NIPER
National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies…
SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults
NEW DELHI: Serum Institute of India has sought permission from India’s drug regulator to conduct a phase-3 study of its Covid-19 vaccine Covovax as a booster dose in adults, official sources said…
Aurobindo, Sun Pharma Recall Products In US Market For Defaulting Norms
New Delhi : Leading homegrown drug makers Aurobindo Pharma and Sun Pharmaceutical Industries are recalling different products in the US market due to deviation from standard manufacturing norms. According to the…
